Qiagen QGEN
NYSE QGEN
$43.71 +0.35 (+0.81%)
As of: Aug 27, 2026 · 3:59 PM EDT

Qiagen (QGEN) Net Income towards Common Stockholders (2009 - 2025)

Qiagen (QGEN) posted Net Income towards Common Stockholders of $522.0 million for Q4 2025, up 301.41% sequentially from $130.0 million in Q3 2025, and up 6.31% YoY from $491.0 million in Q4 2024.

Qiagen (QGEN) Net Income towards Common Stockholders (2009 - 2025) Analysis & Trends

Qiagen has reported Net Income towards Common Stockholders for 17 years, with the latest figure at $522.0 million in Q4 2025.

  • Quarterly Net Income towards Common Stockholders rose 6.31% year-over-year to $522.0 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $784.0 million (down 5.88% YoY) and the FY2025 annual result came in at $522.0 million, up 6.31% from the prior year.
  • Net Income towards Common Stockholders improved to $522.0 million in Q4 2025 per QGEN's latest filing, from $130.0 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $614.0 million in Q4 2021 and troughed at $77.8 million in Q3 2023.
  • A 5-year average of $203.7 million and a median of $123.0 million in 2024 frame the typical range for Net Income towards Common Stockholders.
  • The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders tumbled 80.13% in 2022, then jumped 290.98% in 2023.
  • Over 5 years, Net Income towards Common Stockholders stood at $614.0 million in 2021, then sank by 80.13% to $122.0 million in 2022, then surged by 290.98% to $477.0 million in 2023, then increased by 2.94% to $491.0 million in 2024, then gained by 6.31% to $522.0 million in 2025.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $522.0 million, $130.0 million, and $132.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn 1.76 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn 870.00 Mn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn -66.93 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn 339.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn 241.00 Mn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn 338.41 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn 207.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn 232.90 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn 299.10 Mn
10 Qiagen 9.49 Bn 8.72 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 522.00 Mn
Sep 30, 2025 130.04 Mn
Jun 30, 2025 132.00 Mn
Mar 31, 2025 121.00 Mn
Dec 31, 2024 491.00 Mn
Sep 30, 2024 98.06 Mn
Jun 30, 2024 123.00 Mn
Mar 31, 2024 104.00 Mn
Dec 31, 2023 477.00 Mn
Sep 30, 2023 77.82 Mn
Jun 30, 2023 80.79 Mn
Mar 31, 2023 85.04 Mn
Dec 31, 2022 122.00 Mn
Jun 30, 2022 118.00 Mn
Mar 31, 2022 184.00 Mn
Dec 31, 2021 614.00 Mn
Jun 30, 2021 155.00 Mn
Mar 31, 2021 154.00 Mn
Dec 31, 2020 212.69 Mn
Sep 30, 2020 136.00 Mn